Viewing Study NCT06394661


Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2025-12-30 @ 10:20 AM
Study NCT ID: NCT06394661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-23
First Post: 2024-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module